SRS Capital Advisors »

Ironwood Pharmaceuticals shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of Ironwood Pharmaceuticals (IRWD) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in Ironwood Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ironwood Pharmaceuticals held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ironwood Pharmaceuticals by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $188k 143k 1.31
2024-09-30 $260 63 4.13

More positions owned by SRS Capital Advisors

Vanguard Index Fds Growth Etf (VOO)
Ishares Tr Ishs 1-5yr Invs (OEF)
First Tr Exchange-traded Wtr Etf (FDL)
American Centy Etf Tr Us Large Cap Vlu (KORP)
Dimensional Etf Trust Intl Core Equity (DFAI)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Schwab Strategic Tr Us Tips Etf (SCHB)
Microsoft Corporation (MSFT)
First Tr Exchng Traded Fd Vi Smith Opport Fxd (FIXD)
First Tr Exchange Traded Risng Divd Achiv (FXN)
NVIDIA Corporation (NVDA)
First Tr Exch Traded Fd Iii Pfd Secs Inc Etf (FPE)
Spdr S&p 500 Etf Tr Tr Unit
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for SRS Capital Advisors

Top funds holding Ironwood Pharmaceuticals

Armistice Capital
Vanguard Group
Sarissa Capital Management
BlackRock
UBS Group
Renaissance Technologies
Acadian Asset Management
Kynam Capital Management
AQR Capital Management
Charles Schwab Investment Management
Geode Capital Management
Two Sigma Advisers
State Street Corporation
Marshall Wace
Qube Research & Technologies

View all funds holding Ironwood Pharmaceuticals